In the treatment of glaucoma, the ability of continuous-wave (CW) transscleral laser photocoagulation (TSCPC) to lower intraocular pressure (IOP) must be weighed against its established risks.

Please provide your email address to receive an email when new articles are posted on . A study investigated subthreshold MicroPulse laser therapy for center-involved diabetic macular edema. The ...

MicroPulse ® Transscleral Laser Therapy (TLT), continuous-wave transscleral cyclophotocoagulation (CW-TSCPC), and MicroPulse Laser Trabeculoplasty (MLT) are non-incisional treatments that expand ways ...

MOUNTAIN VIEW, Calif., Dec. 22, 2020 (GLOBE NEWSWIRE) -- IRIDEX Corporation (NASDAQ: IRIX), a provider of innovative ophthalmic laser-based medical products for the treatment of glaucoma and retinal ...

Please provide your email address to receive an email when new articles are posted on . Micropulse transscleral cyclophotocoagulation lowered IOP in pediatric patients with refractory glaucoma, ...

MOUNTAIN VIEW, Calif., Dec. 11, 2025 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and ...

IRIDEX Corp. has announced the launch of a new glaucoma procedure based on its MicroPulse technology, according to a news release. The non-invasive, in-office glaucoma therapy, a tissue-sparing, ...

MOUNTAIN VIEW, Calif., July 10, 2018 (GLOBE NEWSWIRE) -- IRIDEX Corporation (Nasdaq:IRIX) today announced that in the second quarter of 2018 it has shipped the 1,000th unit of its Cyclo G6™ Laser ...